Report Detail
Global Intravitreal Injectable Market 2025 by Company, Regions, Type and Application, Forecast to 2031
- RnM4627330 |
- 26 September, 2025 |
- Global |
- 94 Pages |
- GIR |
- Pharma & Healthcare
According to our latest research, the global Intravitreal Injectable market size will reach USD 29250 million in 2031, growing at a CAGR of 6.9% over the analysis period.
Intravitreal injectables are sterile pharmaceutical formulations administered directly into the vitreous humor of the eye using a fine needle. This route of administration allows for targeted delivery of medications—such as anti-VEGF agents, corticosteroids, or antibiotics—into the posterior segment of the eye, ensuring high local drug concentrations while minimizing systemic exposure. Intravitreal injections are commonly used to treat retinal diseases including age-related macular degeneration (AMD), diabetic macular edema (DME), retinal vein occlusion (RVO), and infectious endophthalmitis.
The global intravitreal injectable market has experienced steady growth in recent years, driven primarily by the rising prevalence of retinal disorders such as macular edema, age-related macular degeneration (AMD), and retinal vein occlusion (RVO). Leading pharmaceutical players in this space include Regeneron Pharmaceuticals (notably with Eylea), Allergan, EyePoint Pharmaceuticals, Genentech, and Kanghong Pharmaceutical. These top five companies collectively account for over 70% of global market share, reflecting a relatively concentrated competitive landscape. North America currently dominates the global market, holding a share of more than 50%, followed by Europe and Asia-Pacific, each with shares exceeding 40%.
In terms of drug types, anti-VEGF (vascular endothelial growth factor) therapies represent the largest and most significant market segment, contributing to over 85% of total market revenue. These agents are highly effective in inhibiting abnormal blood vessel growth in the retina, making them the standard of care for diseases like AMD and diabetic macular edema (DME). Other therapeutic classes such as corticosteroids and antibiotics play smaller roles, typically in more specialized or adjunctive treatment scenarios.
The largest clinical application of intravitreal injectables is for macular edema, which continues to see a rise in incidence linked to diabetes and aging populations worldwide. Macular degeneration and RVO are also major contributors to demand, reinforcing the importance of targeted ophthalmic treatments. The increase in awareness, earlier diagnosis, and improved accessibility to eye care services are further driving market expansion across both developed and emerging regions.
Looking ahead, the market is expected to grow steadily due to increasing disease burden and product innovation. Notably, new players such as Astellas Pharma have begun entering the market, signaling a shift toward broader competition and possibly next-generation therapies with extended efficacy and dosing intervals. Advances in drug delivery systems, longer-acting formulations, and biosimilars are expected to further shape the landscape and offer new growth opportunities.
This report is a detailed and comprehensive analysis for global Intravitreal Injectable market. Both quantitative and qualitative analyses are presented by company, by region & country, by Drug and by Disease. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Intravitreal Injectable market size and forecasts, in consumption value ($ Million), 2020-2031
Global Intravitreal Injectable market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Intravitreal Injectable market size and forecasts, by Drug and by Disease, in consumption value ($ Million), 2020-2031
Global Intravitreal Injectable market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Intravitreal Injectable
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Intravitreal Injectable market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Regeneron Pharmaceuticals (Eylea), Allergan, EyePoint Pharmaceuticals, Genentech, Kanghong Pharmaceutical, Astellas Pharma, Clearside Biomedical, Bayer, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Intravitreal Injectable market is split by Drug and by Disease. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Drug and by Disease. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Drug
Anti-VEGF
Steroids
Others
Market segment by Disease
Macular Degeneration
Macular Edema
Uveitis
Retinal Vein Occlusion
Others
Market segment by players, this report covers
Regeneron Pharmaceuticals (Eylea)
Allergan
EyePoint Pharmaceuticals
Genentech
Kanghong Pharmaceutical
Astellas Pharma
Clearside Biomedical
Bayer
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Intravitreal Injectable product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Intravitreal Injectable, with revenue, gross margin, and global market share of Intravitreal Injectable from 2020 to 2025.
Chapter 3, the Intravitreal Injectable competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Drug and by Disease, with consumption value and growth rate by Drug, by Disease, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Intravitreal Injectable market forecast, by regions, by Drug and by Disease, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Intravitreal Injectable.
Chapter 13, to describe Intravitreal Injectable research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Intravitreal Injectable by Drug
- 1.3.1 Overview: Global Intravitreal Injectable Market Size by Drug: 2020 Versus 2024 Versus 2031
- 1.3.2 Global Intravitreal Injectable Consumption Value Market Share by Drug in 2024
- 1.3.3 Anti-VEGF
- 1.3.4 Steroids
- 1.3.5 Others
- 1.4 Global Intravitreal Injectable Market by Disease
- 1.4.1 Overview: Global Intravitreal Injectable Market Size by Disease: 2020 Versus 2024 Versus 2031
- 1.4.2 Macular Degeneration
- 1.4.3 Macular Edema
- 1.4.4 Uveitis
- 1.4.5 Retinal Vein Occlusion
- 1.4.6 Others
- 1.5 Global Intravitreal Injectable Market Size & Forecast
- 1.6 Global Intravitreal Injectable Market Size and Forecast by Region
- 1.6.1 Global Intravitreal Injectable Market Size by Region: 2020 VS 2024 VS 2031
- 1.6.2 Global Intravitreal Injectable Market Size by Region, (2020-2031)
- 1.6.3 North America Intravitreal Injectable Market Size and Prospect (2020-2031)
- 1.6.4 Europe Intravitreal Injectable Market Size and Prospect (2020-2031)
- 1.6.5 Asia-Pacific Intravitreal Injectable Market Size and Prospect (2020-2031)
- 1.6.6 South America Intravitreal Injectable Market Size and Prospect (2020-2031)
- 1.6.7 Middle East & Africa Intravitreal Injectable Market Size and Prospect (2020-2031)
2 Company Profiles
- 2.1 Regeneron Pharmaceuticals (Eylea)
- 2.1.1 Regeneron Pharmaceuticals (Eylea) Details
- 2.1.2 Regeneron Pharmaceuticals (Eylea) Major Business
- 2.1.3 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product and Solutions
- 2.1.4 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Revenue, Gross Margin and Market Share (2020-2025)
- 2.1.5 Regeneron Pharmaceuticals (Eylea) Recent Developments and Future Plans
- 2.2 Allergan
- 2.2.1 Allergan Details
- 2.2.2 Allergan Major Business
- 2.2.3 Allergan Intravitreal Injectable Product and Solutions
- 2.2.4 Allergan Intravitreal Injectable Revenue, Gross Margin and Market Share (2020-2025)
- 2.2.5 Allergan Recent Developments and Future Plans
- 2.3 EyePoint Pharmaceuticals
- 2.3.1 EyePoint Pharmaceuticals Details
- 2.3.2 EyePoint Pharmaceuticals Major Business
- 2.3.3 EyePoint Pharmaceuticals Intravitreal Injectable Product and Solutions
- 2.3.4 EyePoint Pharmaceuticals Intravitreal Injectable Revenue, Gross Margin and Market Share (2020-2025)
- 2.3.5 EyePoint Pharmaceuticals Recent Developments and Future Plans
- 2.4 Genentech
- 2.4.1 Genentech Details
- 2.4.2 Genentech Major Business
- 2.4.3 Genentech Intravitreal Injectable Product and Solutions
- 2.4.4 Genentech Intravitreal Injectable Revenue, Gross Margin and Market Share (2020-2025)
- 2.4.5 Genentech Recent Developments and Future Plans
- 2.5 Kanghong Pharmaceutical
- 2.5.1 Kanghong Pharmaceutical Details
- 2.5.2 Kanghong Pharmaceutical Major Business
- 2.5.3 Kanghong Pharmaceutical Intravitreal Injectable Product and Solutions
- 2.5.4 Kanghong Pharmaceutical Intravitreal Injectable Revenue, Gross Margin and Market Share (2020-2025)
- 2.5.5 Kanghong Pharmaceutical Recent Developments and Future Plans
- 2.6 Astellas Pharma
- 2.6.1 Astellas Pharma Details
- 2.6.2 Astellas Pharma Major Business
- 2.6.3 Astellas Pharma Intravitreal Injectable Product and Solutions
- 2.6.4 Astellas Pharma Intravitreal Injectable Revenue, Gross Margin and Market Share (2020-2025)
- 2.6.5 Astellas Pharma Recent Developments and Future Plans
- 2.7 Clearside Biomedical
- 2.7.1 Clearside Biomedical Details
- 2.7.2 Clearside Biomedical Major Business
- 2.7.3 Clearside Biomedical Intravitreal Injectable Product and Solutions
- 2.7.4 Clearside Biomedical Intravitreal Injectable Revenue, Gross Margin and Market Share (2020-2025)
- 2.7.5 Clearside Biomedical Recent Developments and Future Plans
- 2.8 Bayer
- 2.8.1 Bayer Details
- 2.8.2 Bayer Major Business
- 2.8.3 Bayer Intravitreal Injectable Product and Solutions
- 2.8.4 Bayer Intravitreal Injectable Revenue, Gross Margin and Market Share (2020-2025)
- 2.8.5 Bayer Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Intravitreal Injectable Revenue and Share by Players (2020-2025)
- 3.2 Market Share Analysis (2024)
- 3.2.1 Market Share of Intravitreal Injectable by Company Revenue
- 3.2.2 Top 3 Intravitreal Injectable Players Market Share in 2024
- 3.2.3 Top 6 Intravitreal Injectable Players Market Share in 2024
- 3.3 Intravitreal Injectable Market: Overall Company Footprint Analysis
- 3.3.1 Intravitreal Injectable Market: Region Footprint
- 3.3.2 Intravitreal Injectable Market: Company Product Type Footprint
- 3.3.3 Intravitreal Injectable Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Drug
- 4.1 Global Intravitreal Injectable Consumption Value and Market Share by Drug (2020-2025)
- 4.2 Global Intravitreal Injectable Market Forecast by Drug (2026-2031)
5 Market Size Segment by Disease
- 5.1 Global Intravitreal Injectable Consumption Value Market Share by Disease (2020-2025)
- 5.2 Global Intravitreal Injectable Market Forecast by Disease (2026-2031)
6 North America
- 6.1 North America Intravitreal Injectable Consumption Value by Drug (2020-2031)
- 6.2 North America Intravitreal Injectable Market Size by Disease (2020-2031)
- 6.3 North America Intravitreal Injectable Market Size by Country
- 6.3.1 North America Intravitreal Injectable Consumption Value by Country (2020-2031)
- 6.3.2 United States Intravitreal Injectable Market Size and Forecast (2020-2031)
- 6.3.3 Canada Intravitreal Injectable Market Size and Forecast (2020-2031)
- 6.3.4 Mexico Intravitreal Injectable Market Size and Forecast (2020-2031)
7 Europe
- 7.1 Europe Intravitreal Injectable Consumption Value by Drug (2020-2031)
- 7.2 Europe Intravitreal Injectable Consumption Value by Disease (2020-2031)
- 7.3 Europe Intravitreal Injectable Market Size by Country
- 7.3.1 Europe Intravitreal Injectable Consumption Value by Country (2020-2031)
- 7.3.2 Germany Intravitreal Injectable Market Size and Forecast (2020-2031)
- 7.3.3 France Intravitreal Injectable Market Size and Forecast (2020-2031)
- 7.3.4 United Kingdom Intravitreal Injectable Market Size and Forecast (2020-2031)
- 7.3.5 Russia Intravitreal Injectable Market Size and Forecast (2020-2031)
- 7.3.6 Italy Intravitreal Injectable Market Size and Forecast (2020-2031)
8 Asia-Pacific
- 8.1 Asia-Pacific Intravitreal Injectable Consumption Value by Drug (2020-2031)
- 8.2 Asia-Pacific Intravitreal Injectable Consumption Value by Disease (2020-2031)
- 8.3 Asia-Pacific Intravitreal Injectable Market Size by Region
- 8.3.1 Asia-Pacific Intravitreal Injectable Consumption Value by Region (2020-2031)
- 8.3.2 China Intravitreal Injectable Market Size and Forecast (2020-2031)
- 8.3.3 Japan Intravitreal Injectable Market Size and Forecast (2020-2031)
- 8.3.4 South Korea Intravitreal Injectable Market Size and Forecast (2020-2031)
- 8.3.5 India Intravitreal Injectable Market Size and Forecast (2020-2031)
- 8.3.6 Southeast Asia Intravitreal Injectable Market Size and Forecast (2020-2031)
- 8.3.7 Australia Intravitreal Injectable Market Size and Forecast (2020-2031)
9 South America
- 9.1 South America Intravitreal Injectable Consumption Value by Drug (2020-2031)
- 9.2 South America Intravitreal Injectable Consumption Value by Disease (2020-2031)
- 9.3 South America Intravitreal Injectable Market Size by Country
- 9.3.1 South America Intravitreal Injectable Consumption Value by Country (2020-2031)
- 9.3.2 Brazil Intravitreal Injectable Market Size and Forecast (2020-2031)
- 9.3.3 Argentina Intravitreal Injectable Market Size and Forecast (2020-2031)
10 Middle East & Africa
- 10.1 Middle East & Africa Intravitreal Injectable Consumption Value by Drug (2020-2031)
- 10.2 Middle East & Africa Intravitreal Injectable Consumption Value by Disease (2020-2031)
- 10.3 Middle East & Africa Intravitreal Injectable Market Size by Country
- 10.3.1 Middle East & Africa Intravitreal Injectable Consumption Value by Country (2020-2031)
- 10.3.2 Turkey Intravitreal Injectable Market Size and Forecast (2020-2031)
- 10.3.3 Saudi Arabia Intravitreal Injectable Market Size and Forecast (2020-2031)
- 10.3.4 UAE Intravitreal Injectable Market Size and Forecast (2020-2031)
11 Market Dynamics
- 11.1 Intravitreal Injectable Market Drivers
- 11.2 Intravitreal Injectable Market Restraints
- 11.3 Intravitreal Injectable Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Intravitreal Injectable Industry Chain
- 12.2 Intravitreal Injectable Upstream Analysis
- 12.3 Intravitreal Injectable Midstream Analysis
- 12.4 Intravitreal Injectable Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Intravitreal Injectable. Industry analysis & Market Report on Intravitreal Injectable is a syndicated market report, published as Global Intravitreal Injectable Market 2025 by Company, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Intravitreal Injectable market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
